Monday, November 30, 2009

Derma Sciences, Inc. (DSCI.OB) Plans Reverse Stock Split

Last week, specialty medical device and pharmaceutical company Derma Sciences, Inc. announced that its shareholders granted Derma Sciences’ Board of Directors the authority to implement a reverse stock split in the range of 1-to-5 and 1-to-10.

Derma Sciences’ Board of Directors anticipates the reverse split to occur in the near future. The precise reverse split ratio will be determined in accordance with the then prevailing market conditions.

For the 20-day period following implementation of the reverse split, Derma Sciences’ ticker symbol will be “DSCID” to reflect the post-split price. Following that period, the ticker symbol will revert to “DSCI.”

Ed Quilty, Chairman and CEO of Derma Sciences, commented, “We have filed an application to list our stock on the NASDAQ Global Market or NASDAQ Capital Market. The reverse stock split our stockholders approved at today’s special meeting will enable Derma Sciences to meet the minimum share-price requirements of the NASDAQ listing.”

About QualityStocks:

QualityStocks’ Small Cap Stock Newsletter is a free service that collects data from hundreds of Small-Cap online Investment Newsletters into one free Daily Newsletter Report.

Sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net

The Quality Stocks Daily Stock Report http://video.qualitystocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks “Ones to Watch” http://Gotstocks.QualityStocks.net

Please see disclaimer on QualityStocks website: http://disclaimer.qualitystocks.net

No comments: